摘要
糖尿病患者更易发生心力衰竭,伴随糖尿病的心力衰竭患者预后更差。目前已有的多种降糖药物对合并糖尿病的心衰患者治疗效果欠佳,有的甚至有害。SGLT2抑制剂是一种新型降糖药,在多项临床研究中发现其对心血管有保护作用。本文就SGLT2抑制剂对心力衰竭的影响做一综述。
A large number of studies have found that patients with diabetes are more likely to have heart failure,heart failure patients with diabetes usually have poorer prognosis,so that heart failure is a very important health problem in elderly diabetics in China.Currently,many kinds of hypoglycemic drugs on the market have poor therapeutic effect on heart failure patients with diabetes,some drugs are even harmful.Cardiovascular protective effect of SGLT2 inhibitors was observed in several clinical studies.In this paper,we are going to summarize the effect of SGLT2 inhibitors on heart failure.
作者
路晨阳
贺秀
景娜
刘永铭
LU Chenyang;HE Xiu;JING Na(reviewing);LIU Yongming(checking)(Department of Geriatrics Cardiology,The First Clinical Medical College of Lanzhou University,The First Hospitalof Lanzhou University,Lanzhou 730000,China)
出处
《西部医学》
2019年第3期470-473,共4页
Medical Journal of West China
基金
国家临床重点专科建设项目(2013-240)
